期刊文献+

^(18)F-FDG PET/CT对腹部增强CT术前评估胰腺癌远处转移的增益价值 被引量:3

Added value of ^(18)F-FDG PET/CT for preoperative evaluation of distant metastasis of pancreatic cancer by abdominal contrast-enhanced CT
下载PDF
导出
摘要 目的研究18F-FDG PET/CT对腹部增强CT术前评估胰腺癌远处转移的增益价值。方法回顾分析51例胰腺癌患者的腹部增强CT和18F-FDG PET/CT资料。通过增强CT、增强CT结合18F-FDG PET/CT评估胰腺癌是否发生远处转移,以病理或随访结果为金标准,分析18F-FDG PET/CT的增益价值。结果增强CT结合18F-FDG PET/CT诊断胰腺癌远处转移的灵敏度、特异度和准确度分别为94.2%(33/35)、100%(16/16)、96.1%(49/51),与单独增强CT的71.4%(25/35)、100%(16/16)、76.5%(41/51)相比,灵敏度和准确度的差异有统计学意义(χ2=6.43,P=0.011;χ2=6.04,P=0.014)。共有26例患者增强CT未检出远处转移,结合18F-FDG PET/CT后,其中6例接近肝包膜直径6.7~9.8 mm的肝转移和2例肺转移被检出。另25例增强CT检出远处转移的患者,结合18F-FDG PET/CT后,评估结果未发生改变。结论18F-FDG PET/CT对于腹部增强CT未检出远处转移的胰腺癌患者有增益价值,尤其是肝内有直径<1 cm且接近肝包膜的微小病灶患者。 Objective To explore the added value of 18F-FDG PET/CT for preoperative evaluation of the distant metastasis of pancreatic cancer by the abdominal contrast-enhanced CT(CE-CT).Methods Data of abdominal CE-CT and F-FDG PET/CT of 51 patients with pancreatic cancer were retrospectively analyzed.The distant metastasis of pancreatic cancer was diagnosed by the CE-CT and CE-CT combined with 18F-FDG PET/CT.Results of pathological diagnosis or follow-up were adopted as the golden standard and the added value of 18F-FDG PET/CT was analyzed.Results The sensitivity,specificity,and accuracy of CE-CT combined with 18F-FDG PET/CT for diagnosing the distant metastasis of pancreatic cancer were 94.2%(33/35),100%(16/16),and 96.1%(49/51).Compared to 71.4%(25/35),100%(16/16),and 76.5%(41/51) of CE-CT,the differences of sensitivity and accuracy were statistically significant(X2=6.43,P=0.Oil;X2=6.04,P=0.014).A total of 26 patients were diagnosed of no distant metastasis by CE-CT,but 6of them were diagnosed of liver metastasis(close to the liver capsule with diameter between 6.7-9.8 mm) and2 of them were diagnosed of lung metastasis by CE-CT combined with F-FDG PET /CT.Another 25 patients were diagnosed of distant metastasis by CE-CT and confirmed by CE-CT combined with 18F-FDG PET/CT.Conclusion 18F-FDG PET /CT provides added value for patients who are diagnosed of pancreatic cancer with no distant metastasis by CE-CT,especially for patients with small liver lesion(diameter 〈 1 cm) close to the liver capsular.
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2014年第12期1762-1766,共5页 Journal of Shanghai Jiao tong University:Medical Science
基金 国家临床重点专科建设项目~~
关键词 胰腺肿瘤 肿瘤转移 PET/CT 增强CT 诊断 pancreatic neoplasms neoplasm metastasis PET/CT contrast-enhanced CT diagnosis
  • 相关文献

参考文献13

  • 1Li D, Xie K, Wolff R, et al. Pancreatic cancer[J]. Lancet, 2004, 363(9414) : 1049 - 1057.
  • 2Wray C J, Ahmad SA, Matthews JB, et al. Surgery for pancreatic cancer : recent controversies and current practice [ J ]. Gastroenterology, 2005, 128(6): 1626-1641.
  • 3彭承宏.重视胰腺癌术前手术可切除性的评估[J].外科理论与实践,2007,12(3):196-198. 被引量:9
  • 4Neoptolemos JP, Stocken DD, Friess H, et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer[J]. N Engl J Med, 2004, 350(7): 1200-1210.
  • 5Strobel K, Heinrich S, Bhure U, et al. Contrast-enhanced 18F- FDG PET/GT: 1-stop-shop imaging for assessing the resectability of pancreatic cancer[J]. J Nucl Med, 2008, 49(9) : 1408 -1413.
  • 6Zamboni GA, Kruskal JB, Vollmer CM, et al. Pancreatic adenocar- cinoma: value of multidetector CT angiography in preoperative evaluation[ J ]. Radiology, 2007, 245 (3) : 770 - 778.
  • 7Diederichs CG, Staib L, Vogel J, et al. Values and limitations of 18F-fluorodeoxyglucose-positron-emission tomography with preopera- tive evaluation of patients with pancreatic masses [ J]. Pancreas, 2000, 20(2) : 109 -116.
  • 8Park JM, Kim IY, Kim SW, et al. A comparative study of FDG PET/CT and enhanced multi-detector CT for detecting liver metasta- sis according to the size and location[ J]. Ann Nucl Med, 2013, 27 (3) : 217 -224.
  • 9Lee KH, Lee JM, Park JH, et al. MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent gadoxetic acid [ J]. Korean J Radiol, 2013, 14 (6) : 894 - 904.
  • 10Dromain C, Leboulleux S, Auperin A, et al. Staging of peritoneal carcinomatosis: enhanced CT vs. PET/CT [ J]. Abdom Imaging, 2008, 33(1): 87-93.

二级参考文献13

  • 1倪泉兴,张延龄.重视胰腺癌病人治疗后远期生存率的评估[J].外科理论与实践,2005,10(3):201-202. 被引量:4
  • 2彭承宏.胰十二指肠切除术术中难点及其处理[J].外科理论与实践,2005,10(3):212-213. 被引量:5
  • 3彭承宏,程东峰,杨卫平,陶宗元,张圣道,李宏为.胰头癌根治术联合血管切除的术中评估和操作要点[J].外科理论与实践,2005,10(3):217-221. 被引量:7
  • 4彭承宏,程东峰,周光文,陶宗元,陈泉宁,林晓珠,扬卫平,李宏为.累及肠系膜上静脉的胰腺钩突肿瘤的临床分级及其意义[J].中华外科杂志,2006,44(5):317-320. 被引量:7
  • 5O'Neil S,Pickleman J,Aranha GV.Pancreaticogastrostomy following pancreaticoduodenectomy:review of 102 consecutive cases[J].World J Surg,2001,25(5):567-571.
  • 6Berherat PO,Friess H,Kleeff J,et al.Prevention and treatment of complications in pancreatic cancer surgery[J].Dig Surg,1999,16(4):327-336.
  • 7Jemal A,Murray T,Ward E,et al.Cancer statistics,2005[J].CA Cancer J Clin,2005,55(1):10-30.
  • 8Andren-Sandberg A,Neoptolemos JP.Resection for pancreatic cancer in the new millennium[J].Pancreatology,2002,2(5):431-439.
  • 9Capussotti L,Massucco P,Ribero D,et al.Extended lymphadenectomy and vein resection for pancreatic head cancer:outcomes and implications for therapy[J].J Arch Surg,2003,138(12):1316-1322.
  • 10Farnell MB,Pearson RK,Sarr MG,et al.A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable panereatic head adenocarcinoma[J].Surgery,2005,138(4):618-628.

共引文献8

同被引文献31

  • 1Alamo JM, Marln LM, Suarez G, et al. hnproving outcomes in pancreatic cancer: key points in perioperative management [ J]. World J Gastroenterol, 2014, 20(39) : 14237 -14245.
  • 2Long EE, Van Dam J, Weinstein S, et al. Computed tomography, endoscopic, laparoscopic, and intra-operative sonography for assess- ing resectability of pancreatic cancer [J].Surg Oncol, 2005, 14 (2): 105-113.
  • 3Hillner BE, Siegel BA, Liu D, et al. Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the National Oncologic PET Registry[ J]. J Clin Oncol, 2008, 26(13): 2155-2161.
  • 4Diederichs CG, Staib L, Vogel J, et al. Values and limitations of ~SF_fluorodeoxyglucose_positron.emission tomography with preopera- tive evaluation of patients with pancreatic masses [ J ]. Pancreas, 2000, 20(2) : 109 - 116.
  • 5Strobel K, Heinrich S, Bhure U, ctal. Contrast-e~hanced ~8 F-FDG PET/CT: 1-stop-shop imaging for assessing the resectability of pancreatic cancer[J]. J Nucl Med, 2008, 49(9): 1408-1413.
  • 6Seo H J, Kim M J, Lee JD, et al. Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced lS F-fluorode-oxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases [J].Invest Radiol, 2011, 46(9): 548 -555.
  • 7Park JM, Kim IY, Kim SW, et al. A comparative study of FDG PET/CT and enhanced multi-detector CT for detecting liver metastasis according to the size and location[J].Ann Nucl Med, 2013, 27 (3) : 217 -224.
  • 8Li D, Xie K, Wolff R, et al. Pancreatic cancer[ J]. Lancet, 2004, 363 (9414) : 1049 - 1057.
  • 9Dromain C, Leboulleux S, Auperin A, et al. Staging of peritoneal carcinomatosis: enhanced CT vs. PET/CT [J].Abdom Imaging, 2008, 33(1): 87-93.
  • 10Soussan M, Des Guetz G, Barrau V, et ah Comparison of FDG- PET/CT and MR with diffusion-v,'eighted imaging for assessing peritoneal carcinomatosis from gastrointestinal malignancy [ J ]. Eur Radiol, 2012, 22(7) : 1479 - 1487.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部